SELECTED TALKS & ARTICLES

This patent covers AI-designed peptide agonists of the melanocortin-4 receptor (MC4R) for the treatment of obesity, designed to have reduced side effects due to improved receptor selectivity. The peptides were developed through a collaboration between ProteinQure and Flagship Pioneering Medicines.

Invited talk: Scaling Drug Discovery to Petascale

March 14, 2021
CAMDEA Digital Forum

Invited talk on scaling ProteinQure’s ML-driven peptide and protein design platform to petascale performance on AWS using Kubernetes and Argo Workflows.

Our latest work introduces PeptideMPNN, a finetuned structure-to-sequence model for peptide binder design, presented at the NeurIPS Machine Learning for Structural Biology workshop.

Interview: Computational Protein Drug Discovery

September 4, 2023
BOLD Community

Interview with the BOLD Community discussing my founder journey, bold decision-making, and lessons from scaling a computational biotech.

Featured in Toronto Life for commentary on the problem-solving potential of quantum computing (“Four industry leaders on the mind-boggling problem-solving potential of quantum computing”, 2023) alongside some lighthearted personal questions.

Panel: QC in Pharma: vendor perspective

February 15, 2021
Q2B conference

Invited panelist at Q2B 2021 alongside Forbes, Qu&Co and Accenture, speaking on how quantum computing and quantum-inspired hybrid methods could support protein design and computational drug discovery.

Invited talk: Learning Curves of Quantum Kernel Machines

May 27, 2022
NITheCS Webinar

In this webinar I am presenting an overview of my Master’s research in quantum machine learning and statistical physics. I present a curated set of theoretical and numerical tools for quantum kernel analysis and design.

Interested in having me speak?